A detailed history of Manufacturers Life Insurance Company, The transactions in Exact Sciences Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 103,453 shares of EXAS stock, worth $4.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
103,453
Previous 70,041 47.7%
Holding current value
$4.37 Million
Previous $5.18 Million 37.89%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$56.27 - $73.77 $1.88 Million - $2.46 Million
33,412 Added 47.7%
103,453 $7.14 Million
Q4 2023

Feb 13, 2024

SELL
$59.06 - $75.72 $588,591 - $754,625
-9,966 Reduced 12.46%
70,041 $5.18 Million
Q3 2023

Nov 15, 2023

SELL
$65.94 - $99.04 $3.2 Million - $4.8 Million
-48,466 Reduced 37.72%
80,007 $5.46 Million
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $857,650 - $1.3 Million
13,683 Added 11.92%
128,473 $12.1 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $347,743 - $521,504
7,369 Added 6.42%
122,159 $8.28 Million
Q4 2022

Aug 11, 2023

SELL
$30.35 - $53.15 $215,333 - $377,099
-7,095 Reduced 5.82%
114,790 $5.68 Million
Q4 2022

Feb 13, 2023

SELL
$30.35 - $53.15 $215,333 - $377,099
-7,095 Reduced 5.82%
114,790 $5.68 Million
Q3 2022

Aug 11, 2023

SELL
$31.97 - $49.37 $9,622 - $14,860
-301 Reduced 0.25%
121,885 $3.96 Million
Q3 2022

Nov 03, 2022

SELL
$31.97 - $49.37 $9,622 - $14,860
-301 Reduced 0.25%
121,885 $4.01 Million
Q2 2022

Aug 11, 2023

BUY
$35.61 - $76.23 $343,921 - $736,229
9,658 Added 8.58%
122,186 $4.81 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $343,921 - $736,229
9,658 Added 8.58%
122,186 $4.91 Million
Q1 2022

Aug 11, 2023

SELL
$57.56 - $82.54 $554,360 - $794,942
-9,631 Reduced 7.88%
112,528 $7.87 Million
Q1 2022

May 20, 2022

BUY
$57.56 - $82.54 $4.25 Million - $6.1 Million
73,846 Added 190.91%
112,528 $7.96 Million
Q4 2021

Feb 16, 2022

BUY
$72.5 - $100.68 $59,885 - $83,161
826 Added 2.18%
38,682 $3.01 Million
Q3 2021

Nov 12, 2021

BUY
$90.24 - $124.05 $683,297 - $939,306
7,572 Added 25.0%
37,856 $3.61 Million
Q2 2021

Aug 12, 2021

SELL
$93.66 - $139.27 $41,491 - $61,696
-443 Reduced 1.44%
30,284 $3.77 Million
Q1 2021

May 03, 2021

SELL
$116.57 - $155.01 $1.76 Million - $2.33 Million
-15,063 Reduced 32.9%
30,727 $4.05 Million
Q4 2020

Feb 12, 2021

SELL
$99.61 - $142.12 $2.07 Million - $2.95 Million
-20,778 Reduced 31.21%
45,790 $6.07 Million
Q3 2020

Nov 09, 2020

BUY
$72.92 - $102.01 $1.15 Million - $1.61 Million
15,762 Added 31.02%
66,568 $6.79 Million
Q2 2020

Aug 10, 2020

BUY
$55.75 - $92.75 $2.64 Million - $4.39 Million
47,320 Added 1357.43%
50,806 $4.37 Million
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $133,938 - $369,090
-3,534 Reduced 50.34%
3,486 $202,000
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $286,798 - $368,339
3,693 Added 111.0%
7,020 $649,000
Q3 2019

Nov 12, 2019

SELL
$90.37 - $122.49 $1,445 - $1,959
-16 Reduced 0.48%
3,327 $306,000
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $33,566 - $44,265
375 Added 12.63%
3,343 $395,000
Q1 2019

May 13, 2019

BUY
$61.98 - $96.5 $183,956 - $286,412
2,968 New
2,968 $257,000
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $166,326 - $245,334
-2,968 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $18,108 - $30,224
-375 Reduced 11.22%
2,968 $234,000
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $3.17 Million - $5.85 Million
-83,657 Reduced 96.16%
3,343 $200,000
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $81,511 - $117,763
-2,047 Reduced 2.3%
87,000 $3.51 Million
Q4 2017

Feb 08, 2018

SELL
$46.49 - $60.51 $13,110 - $17,063
-282 Reduced 0.32%
89,047 $4.68 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $3.31 Million - $4.21 Million
89,329
89,329 $4.21 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.48B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.